NXTC
Ticker
NextCure, Inc.
NXTC · Healthcare · NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancerNextCure, Inc. (NXTC), in the Healthcare sector, has 2 disclosed filings on Paydirt over the trailing twelve months from 2 corporate insiders: 1 purchase and 1 sale. Filers took a median of 3 days from execution to disclosure, and the most recent trade was executed Aug 10 and filed Aug 12. The most active filer was ADAR1 Capital Management, LLC with 1 filing.
Add to watchlistFilings, ttm
2
1 buy · 1 sell
Traders, ttm
2
2 insiders
Volume, ttmiDollar value disclosed in the window
$1.8M
estimated for Congress, as filed for insiders
Median delay
3d
execution to disclosure
Last traded
Aug 10
Filed Aug 12
ADViAverage daily dollar volume
$9.4M
market data
Share price · 12M
$5.89 (+5.9%)
Adjusted for splits and dividends.
Volume by month
Buys $1.6M
Sells $185K
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
AL
ADAR1 Capital Management, LLC
10% owner
1 filing
SI
Simcere Zaiming, Inc.
Other
1 filing
Recent filings
Simcere Zaiming, Inc.SALE
Other
$185K30,000 sh × $6.16
Exec Aug 10
Filed Aug 12 · 11:35 AM ET ADAR1 Capital Management, LLCPURCHASE 10% owner $1.6M
317,850 sh across 7 lots
Exec Jul 30
Filed Aug 3 · 5:53 PM ET